Home > PB Ratio > SYNCOM FORMULATIONS (INDIA)

SYNCOM FORMULATIONS (INDIA)
PB (Price/Book ) Ratio

The Current P/B Ratio of SYNCOM FORMULATIONS (INDIA) is 7.10.

Share Price ₹21.8Dec 12,2024
Market Cap ₹2,045.4 Cr
Book Value₹288.1 CrMar2024 - Consolidated Results
Price/Book 7.10xCalculated as MarketCap/Book Value
Explore Stock Analytics
COMMUNITY POLL
for SYNCOM FORMULATIONS (INDIA)
Please provide your vote to see the results
SYNCOM FORMULATIONS (INDIA) is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks

Definition & Calculation of PB (Price/Book ) ratio of SYNCOM FORMULATIONS (INDIA)

Price-to-Book ratio, P/B Multiple, or P/B Ratio is an important valuation multiple that is defined as:

P/B = Market Capitalization / Book Value

or, using per-share numbers:

P/B = Stock Price / Book Value Per Share

Applying the above formula, P/B ratio of SYNCOM FORMULATIONS (INDIA) is calculated as :

Current Market Cap [ ₹2,045.4 Cr] as on Dec 12,2024

(/) Book Value [ ₹288.1 Cr] based on Mar2024 - Consolidated Results

(=) P/B Ratio [ 7.10x ]

P/B Ratio indicates 'the multiple of book value' investors are willing to pay to own one share of the company.

Thus, for SYNCOM FORMULATIONS (INDIA) , the investors are currently willing to pay '7.10 times book value' to own 1 share of the company.

PB Multiples are one of the most widely used valuation multiple in industry.

Since P/B ratio uses Book Value in the calculation, P/B multiples are not always reliable for valuing companies with negative book value.

In such cases, you may consider using Price to Earnings ratio or Price to Sales ratio of SYNCOM FORMULATIONS (INDIA) !

The chart below summarizes the trend in P/B Ratio of SYNCOM FORMULATIONS (INDIA) over the last five years.

Historical PB (Price/Book ) ratio chart of SYNCOM FORMULATIONS (INDIA)


PB Ratio Performance Analysis for SYNCOM FORMULATIONS (INDIA)

- SYNCOM FORMULATIONS (INDIA) 's latest p/b ratio is 7.10x.

- SYNCOM FORMULATIONS (INDIA) 's p/b ratio for fiscal years ending Mar2024 to Mar2016 averaged 2.59x.

- SYNCOM FORMULATIONS (INDIA) 's operated at median p/b ratio of 2.17x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, SYNCOM FORMULATIONS (INDIA) 's p/b ratio peaked in Mar2022 at 4.22x.

- SYNCOM FORMULATIONS (INDIA) 's p/b ratio hit its five-year low in Mar2017 of 1.31x.


How does SYNCOM FORMULATIONS (INDIA) 's P/B Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Book ValuePB RatioMarket Cap
SYNCOM FORMULATIONS (INDIA) 288.147.102,045.4
SUN PHARMACEUTICAL INDUSTRIES LTD63,666.806.80432,948.0
CIPLA LTD26,619.904.39116,809.0
DR REDDYS LABORATORIES LTD28,123.503.70103,963.0
ZYDUS LIFESCIENCES LTD19,829.504.9598,173.2
DIVIS LABORATORIES LTD13,571.0011.63157,873.0
MANKIND PHARMA LTD9,339.8411.37106,198.0
TORRENT PHARMACEUTICALS LTD6,856.1516.43112,643.0
LUPIN LTD14,175.806.8196,581.6
AUROBINDO PHARMA LTD29,842.802.3670,576.1
ABBOTT INDIA LTD3,658.7316.6861,032.5

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PB Analysis vs SYNCOM FORMULATIONS (INDIA) 's P/B Ratio

Top 10 Industry PeersPB Ratio
Min industry PB 2.36x
Max industry PB 16.68x
Median industry PB 6.81x
Average industry PB 8.38x



You may also like the below Video Courses